This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition.
First, the recommendation to discontinue the regimen based on just 2 months of rifampicin (2HRZE...
This is a dynamic and challenging time for those working in public health, in global health cooperation, and in tuberculosis control specifically. As a result of commitments to health at the highest political levels, there are unprecedented opportunities for expanding response to disease epidemics and si...
Until very recently, the approaches to TB care and control have been focused in most
settings on the essential public health and medical interventions with very limited
scope to contribution by communities. And yet, the issue of community involvement
in public health approaches and in the delivery of hea...
